Analysts Provide Insight On Celgene Corporation And Receptos, Inc. In Light Of Acquisition Announcement
July 16, 2015 at 12:08 PM EDT
Celgene will pay $7.2 billion in cash for the autoimmune drug maker. The boards of both companies have approved the terms of the acquisition and expect it to close before the end of the quarter.
